SE8300913L - Topical ocular application of 3-aryloxy-2-hydroxy propylamine derivs. - for treating without systemic beta-blocker side-effects - Google Patents

Topical ocular application of 3-aryloxy-2-hydroxy propylamine derivs. - for treating without systemic beta-blocker side-effects

Info

Publication number
SE8300913L
SE8300913L SE8300913A SE8300913A SE8300913L SE 8300913 L SE8300913 L SE 8300913L SE 8300913 A SE8300913 A SE 8300913A SE 8300913 A SE8300913 A SE 8300913A SE 8300913 L SE8300913 L SE 8300913L
Authority
SE
Sweden
Prior art keywords
aryloxy
treating
alkenyl
topical ocular
derivs
Prior art date
Application number
SE8300913A
Other languages
English (en)
Swedish (sv)
Other versions
SE8300913D0 (sv
SE462075B (sv
Inventor
W Matier
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of SE8300913D0 publication Critical patent/SE8300913D0/
Publication of SE8300913L publication Critical patent/SE8300913L/
Publication of SE462075B publication Critical patent/SE462075B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE8300913A 1981-06-23 1983-02-18 Oftalmologisk komposition foer behandling av glukom innehaallande kortverkande b-blockerande foereningar SE462075B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,658 US4454154A (en) 1981-06-23 1981-06-23 Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents

Publications (3)

Publication Number Publication Date
SE8300913D0 SE8300913D0 (sv) 1983-02-18
SE8300913L true SE8300913L (en) 1983-02-18
SE462075B SE462075B (sv) 1990-05-07

Family

ID=23057573

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8300913A SE462075B (sv) 1981-06-23 1983-02-18 Oftalmologisk komposition foer behandling av glukom innehaallande kortverkande b-blockerande foereningar

Country Status (17)

Country Link
US (1) US4454154A ( )
EP (1) EP0082873B1 ( )
JP (1) JPH0653663B2 ( )
AU (1) AU565752B2 ( )
CA (1) CA1188224A ( )
CH (1) CH654205A5 ( )
ES (1) ES513387A0 ( )
GB (1) GB2111387B ( )
GR (1) GR76847B ( )
IL (1) IL66070A ( )
IT (1) IT1156058B ( )
NL (1) NL8220252A ( )
NZ (1) NZ200972A ( )
PH (1) PH18970A ( )
SE (1) SE462075B ( )
WO (1) WO1983000014A1 ( )
ZA (1) ZA824340B ( )

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5334601A (en) * 1984-03-14 1994-08-02 Bodor Nicholas S Soft β-adrenergic blocking agents
US5202347A (en) * 1984-03-14 1993-04-13 Bodor Nicholas S Soft β-adrenergic blocking agents
US5135926A (en) * 1984-03-14 1992-08-04 Bodor Nicholas S Soft β-adrenergic blocking agents
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
ATE76750T1 (de) * 1987-04-03 1992-06-15 Univ Columbia Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
CA1334168C (en) * 1988-04-26 1995-01-31 Louis M. De Santis Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers
US4857552A (en) * 1988-06-08 1989-08-15 E. I. Du Pont De Nemours And Co. Stable pharmaceutical composition
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents
US6197817B1 (en) 1999-01-22 2001-03-06 Selectus Pharmaceuticals, Inc. Phenylpropionic acids and esters: compounds and methods for inducing beta-blockade for the treatment of cardiac disorders
BRPI0511462A (pt) * 2004-05-25 2007-12-26 Othera Pharmaceuticals Inc medicamentos e pró-medicamentos óculo-seletivos

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868460A (en) * 1967-02-06 1975-02-25 Boehringer Sohn Ingelheim Therapeutic compositions and method
DE1593762A1 (de) * 1967-02-06 1972-06-08 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen substituierten 1-Phenoxy-2-hydroxy-3-alkylaminopropanen
US3740444A (en) * 1968-01-25 1973-06-19 Boehringer Sohn Ingelheim Therapeutic compositions and method
GB1285038A (en) * 1969-02-21 1972-08-09 Ici Ltd Alkanolamine derivatives
DE1922003C3 (de) * 1969-04-30 1979-10-11 Boehringer Mannheim Gmbh, 6800 Mannheim N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz
DE2048838A1 (de) * 1970-10-05 1972-04-06 C H Boehnnger Sohn, 6507 Ingel heim Neue 1 Phenoxy 2 hydroxy 3 hydroxyal kylaminopropane und Verfahren zu ihrer Her stellung
FR2132570B1 ( ) * 1971-04-09 1974-08-02 Lipha
JPS4875539A ( ) * 1972-01-12 1973-10-11
JPS49247A ( ) * 1972-04-17 1974-01-05
US3839584A (en) * 1972-08-31 1974-10-01 Interx Research Corp Pharmaceutical compositions containing a novel ester of ((methylamino)methyl)benzyl alcohol and methods of using same
AT330150B (de) * 1973-02-28 1976-06-10 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen 1-phenoxy-2-hydroxy -3- propargylaminopropanen und von deren saureadditionssalzen
US3825583A (en) * 1973-04-26 1974-07-23 Interx Research Corp Ester of 3-hydroxy-alpha-((methylamino)methyl)benzyl alcohol
US4195085A (en) * 1975-09-26 1980-03-25 Merck & Co., Inc. Compositions and methods for treating glaucoma by the topical administration of t-butylamino-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy-2-phopanol hydrogen maleate
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
US4191765A (en) * 1976-05-25 1980-03-04 Hoechst Aktiengesellschaft 1-Aryloxy-2-hydroxy-3-aminopropanes
US4080471A (en) * 1976-06-25 1978-03-21 Aktiebolaget Hassle Use of substituted isopropylaminopropanols for inducing inotropic effects of the human heart
DE2752659A1 (de) * 1976-12-07 1978-06-08 Sandoz Ag Neue tetralinderivate, ihre herstellung und verwendung
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
EP0003664B1 (en) * 1978-02-08 1982-02-17 Imperial Chemical Industries Plc Alkanolamine derivatives, process for their preparation and pharmaceutical compositions containing them
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
SE8004088L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ...
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders

Also Published As

Publication number Publication date
ZA824340B (en) 1983-04-27
AU565752B2 (en) 1987-09-24
PH18970A (en) 1985-11-26
IL66070A0 (en) 1982-09-30
NL8220252A (nl) 1983-05-02
GB8303061D0 (en) 1983-03-09
ES8401928A1 (es) 1984-01-01
NZ200972A (en) 1986-10-08
EP0082873A4 (en) 1983-11-11
IT1156058B (it) 1987-01-28
GB2111387A (en) 1983-07-06
EP0082873A1 (en) 1983-07-06
JPS58500996A (ja) 1983-06-23
AU8737482A (en) 1983-01-18
IT8267796A0 (it) 1982-06-22
SE8300913D0 (sv) 1983-02-18
CA1188224A (en) 1985-06-04
SE462075B (sv) 1990-05-07
IL66070A (en) 1987-03-31
GR76847B ( ) 1984-09-04
JPH0653663B2 (ja) 1994-07-20
WO1983000014A1 (en) 1983-01-06
CH654205A5 (de) 1986-02-14
GB2111387B (en) 1986-02-05
US4454154A (en) 1984-06-12
EP0082873B1 (en) 1988-12-07
ES513387A0 (es) 1984-01-01

Similar Documents

Publication Publication Date Title
ES2042625T5 (es) Uso de una prostaglandina en combinacion con un agente bloqueante adrenergico para la reduccion de presion intraocular.
SE8300913L (en) Topical ocular application of 3-aryloxy-2-hydroxy propylamine derivs. - for treating without systemic beta-blocker side-effects
ATE207360T1 (de) Behandlung von augenhochdruck mit betablockern und prostansäurederivaten
ES8604516A1 (es) Un derivado de dihidropiridina
CA2274819A1 (en) Method for treating cellulosic shaped bodies
AU695322B2 (en) Liposome eye drops
ES8401927A1 (es) Procedimiento de obtencion de composiciones oftalmologicas.
IE881734L (en) Oxazolidin-2-one derivatives as hypoglycemic agents
BR9709916A (pt) Processo para o tratamento de fibras de celulose e de conjuntos feitos destas fibras
DE69106777T2 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
ATE132750T1 (de) Behandlung von intraokularem druck mit einer synergischen kombination
SE8300914L (en) Topical ocular application of 3-acyloxy-2-hydroxy propylamine derivs. - for treating glaucoma and reducing intra=ocular pressure without systemic beta-blocker side-effects
ES8405358A1 (es) Procedimiento de obtencion de agentes de beta bloqueantes conteniendo grupos de ester con propiedades oftalmologicas.
DK645489A (da) Antiglaukompraeparater indeholdende kombinationer af sympatomimetiske midler og beta-1 selektive beta-blokkere
WO1998001099A3 (en) Method of treating retinal ischemia and glaucoma
HU9301364D0 (en) Homo-prostaglandines applicables for treatment of hypertension in eyes
FR2457338A1 (fr) Procede pour la protection des matieres cellulosiques au cours de leurs traitements par des solutions alcalines
IT1104703B (it) Derivati di 2,3-difenil-cromone loro procedimento di preparazione e loro applicazione terapeutica

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8300913-4

Effective date: 19940110

Format of ref document f/p: F